Trial Profile
Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Neridronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Adverse reactions
- Sponsors Grunenthal
- 11 Jan 2019 Status changed from active, no longer recruiting to completed.
- 16 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Dec 2016 Status changed from not yet recruiting to recruiting.